Mining drug–disease relationships as a complement to medical genetics‐based drug repositioning: Where a recommendation system meets genome‐wide association studies

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|97|5|451-454

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.97, Iss.5, 2015-05, pp. : 451-454

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alcohol Dependence Genetics: Lessons Learned From Genome‐Wide Association Studies (GWAS) and Post‐GWAS Analyses

By  

ALCOHOLISM (ELECTRONIC), Vol. 39, Iss. 8, 2015-08 ,pp. : 1312-1327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cancer genetic association studies in the genome-wide age

By Savage Sharon A  

Personalized Medicine, Vol. 5, Iss. 6, 2008-11 ,pp. : 589-597

Future Medicine

Access to resources Recommend Favorite

Genome‐wide association studies in biliary atresia

By  

WILEY INTERDISCIPLINARY REVIEWS: SYSTEMS BIOLOGY AND MEDICINE (ELECTRONIC), Vol. 7, Iss. 5, 2015-09 ,pp. : 267-273

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genome‐wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 5, 2015-05 ,pp. : 518-525

John Wiley & Sons Inc

Access to resources Recommend Favorite

Probability of detecting disease-associated single nucleotide polymorphisms in case-control genome-wide association studies

By Gail Mitchell H.   Pfeiffer Ruth M.   Wheeler William   Pee David  

Biostatistics, Vol. 9, Iss. 2, 2008-04 ,pp. : 201-215

Oxford University Press

Access to resources Recommend Favorite